The FDA has made a big change. They want to take off the suicide warning from popular weight loss drugs like Wegovy and Zepbound. This news comes after they looked at lots of data and found no link between these drugs and suicidal thoughts. These drugs, known as GLP-1, were first made to help peopl
MannKind, a company focused on treating long-term illnesses, had a strong finish to 2025. They acquired another company, scPharmaceuticals, and made over $100 million in their last quarter. This success has set the stage for an exciting 2026, with two major products potentially hitting the market.
The FDA has made a big change. They are asking drug companies to remove the strongest warnings from menopause hormone treatments. These warnings, called "black box" warnings, alert users to serious risks. The FDA looked at lots of studies and got advice from experts before making this decision. The
The Food and Drug Administration (FDA) recently declared that the shortage of branded tirzepatide is over. This decision has significant implications for patients and compounding pharmacies. For patients like Willow Baillies, who relied on compounded, cheaper versions of the drug to manage weight lo
The U. S. Food and Drug Administration (FDA) announced that there are no longer shortages of Eli Lilly’s popular weight-loss and diabetes drugs. This decision stops the widespread sale of cheaper, unapproved copies made by compounding pharmacies. The FDA will not take action against these pharmacies
